<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04212585</url>
  </required_header>
  <id_info>
    <org_study_id>H.Pylori status</org_study_id>
    <nct_id>NCT04212585</nct_id>
  </id_info>
  <brief_title>The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital</brief_title>
  <official_title>The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to estimate the prevalence of Helicobacter pylori infection among
      Egyptian children attending to healthcare facilitates using different diagnostic tools.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of H. pylori infection, which has a ubiquitous distribution, varies depending
      on socioeco- nomic factors and age. in the context of a decreased trend in H. pylori
      prevalence, at least 50% of the world's hu-man population are carriers of the microorganism,
      with a prevalence much higher in developing countries than in developed countries. H. pylori
      infection was evaluated in 286 Egyptian school children, and the overall prevalence was &gt;
      72%. Acquisition of the infection occurs mostly in early childhood; therefore, a better
      understanding of the epidemiology and the risk factors associated with H. pylori infection in
      the pediatric population is important to clarify the natural history and complications of the
      infection and programming eradication strategies.

      Currently, little data exist regarding the epidemiology of H. pylori associated infection in
      our region., especially in children. Therefore, this study aims to determine the prevalence
      of H. pylori among children.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of H. pylori in children hospital attendees.</measure>
    <time_frame>2 years</time_frame>
    <description>We need to estimate prevalence of H.Pylori infection among all children admitted in Assiut University Hospital.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <arm_group>
    <arm_group_label>children with upper gastrointestinal symptoms</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>children without upper gastrointestinal symptoms</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serology test</intervention_name>
    <description>Serology for Helicobacter pylori (immunoglobulin G for all sites, immunoglobulin M optional, immunoglobulin A optional) will be collected from all participants. 90 samples (immunoglobulin G, immunoglobulin M and immunoglobulin A) at least needed from each site.
Stool antigen for Helicobacter pylori</description>
    <arm_group_label>children with upper gastrointestinal symptoms</arm_group_label>
    <arm_group_label>children without upper gastrointestinal symptoms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Egyptian Children aged from 0 years to 18 years old.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All children (&lt;18 years) attending healthcare facilities for any reason will be
             enrolled after informed consent of their parents to participate in the study.

        Participants will be recruited from the following sources:

          1. Children with non-GI symptoms (ophthalmology, ear, nose, and throat , chest
             departments .. etc)

          2. Children with GI symptoms undergoing upper GI endoscopy (from GI endoscopy units).

        Simple questionnaire will be used to collect demographic data, socioeconomic status,
        dietary habits, and gastrointestinal complaints from parents of all participants before
        testing for Helicobacter pylori.

        Exclusion Criteria:

          1. Patients refusing to be enrolled in the study.

          2. For any diagnostic test other than serology (stool antigen, rapid Urease test, urea
             breath test, histopathology) the following patients will be excluded:

               -  Children received any antibiotics in the last month

               -  Children received bismuth compounds in the last month.

               -  Children received proton pump inhibitors in the last 2 weeks.

               -  Children presenting with upper gastrointestinal bleeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magda S Hasan, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ebtihal R Hashem, MB</last_name>
    <phone>+201060633506</phone>
    <email>ebtihalrhs2015@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohammed A Medhat Nasr, M.D.</last_name>
    <phone>+201099922736</phone>
    <email>mmedhat83@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Blecker U. Helicobacter pylori-associated gastroduodenal disease in childhood. South Med J. 1997 Jun;90(6):570-6; quiz 577. Review.</citation>
    <PMID>9191731</PMID>
  </reference>
  <reference>
    <citation>Tonkic A, Tonkic M, Lehours P, MÃ©graud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter. 2012 Sep;17 Suppl 1:1-8. doi: 10.1111/j.1523-5378.2012.00975.x. Review.</citation>
    <PMID>22958148</PMID>
  </reference>
  <reference>
    <citation>Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: impact of social background and effect on growth. Public Health Nutr. 2008 Mar;11(3):230-6. Epub 2007 Aug 1.</citation>
    <PMID>17666124</PMID>
  </reference>
  <reference>
    <citation>Takahashi M, Kimura H, Watanabe K. Helicobacter pylori infection in patients with idiopathic short stature. Pediatr Int. 2002 Jun;44(3):277-80.</citation>
    <PMID>11982896</PMID>
  </reference>
  <reference>
    <citation>Malaty HM, Logan ND, Graham DY, Ramchatesingh JE, Reddy SG. Helicobacter pylori infection in asymptomatic children: comparison of diagnostic tests. Helicobacter. 2000 Sep;5(3):155-9.</citation>
    <PMID>10971680</PMID>
  </reference>
  <reference>
    <citation>Roma E, Miele E. Helicobacter pylori Infection in Pediatrics. Helicobacter. 2015 Sep;20 Suppl 1:47-53. doi: 10.1111/hel.12257. Review.</citation>
    <PMID>26372825</PMID>
  </reference>
  <reference>
    <citation>Sustmann A, Okuda M, Koletzko S. Helicobacter pylori in children. Helicobacter. 2016 Sep;21 Suppl 1:49-54. doi: 10.1111/hel.12341. Review.</citation>
    <PMID>27531540</PMID>
  </reference>
  <reference>
    <citation>Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015 Jan 15;136(2):487-90. doi: 10.1002/ijc.28999. Epub 2014 Jun 11.</citation>
    <PMID>24889903</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 24, 2019</study_first_submitted>
  <study_first_submitted_qc>December 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2019</study_first_posted>
  <last_update_submitted>December 28, 2019</last_update_submitted>
  <last_update_submitted_qc>December 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ebtihal Ramadan Hashem</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

